The Alamandine/MrgprD as a Key Player in Antiresorptive Effects in an Osteoporosis Experimental Model
Calcified Tissue International · 09.03.2026 · 117 (1)
DOI: 10.1007/s00223-025-01465-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Calcified Tissue International, online erschienen am 09.03.2026. Verfasst von Letícia Cristina Dias Lima und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Av. Antonio Carlos, 6627, Pampulha, Belo Horizonte,…. Hauptthemen laut MEDLINE: Osteoporosis, Bone Resorption, Oligopeptides, Receptors, G-Protein-Coupled. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de Minas Gerais.
Abstract (Originalsprache)
The renin-angiotensin system plays a key role in bone metabolism. While the classical renin-angiotensin system axis promotes bone resorption, the counter-regulatory axis, including alamandine via MrgprD receptor, favors bone formation. This study evaluated the therapeutic effects of alamandine in a model of osteoporosis. In vitro, alamandine reduced osteoclast activation and size in a MrgprD receptor-dependent manner. In vivo, ovariectomy-induced osteoporosis reduced bone parameters, and alamandine reversed trabecular bone loss in wild-type mice but not in MrgprD knockout mice, demonstrating the essential role of the receptor. Alamandine also reduced serum calcium and phosphorus levels in ovariectomized wild-type mice, with no effect on ovariectomized knockout animals. Furthermore, modulation of iron levels differed between genotypes, suggesting the involvement of ferroptosis-related pathways. Histological analysis revealed an increase in the number of osteoblasts and osteocytes in wild-type mice treated with alamandine, corroborating its role in osteogenic differentiation, possibly via the AMPK/eNOS pathway. In contrast, alamandine exacerbated bone resorption in ovariectomized MrgprD knockout mice, potentially through alternative renin-angiotensin system receptors. In conclusion, alamandine increases bone formation and reduces resorption through MrgprD receptor signaling, highlighting its potential as a therapeutic agent in osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Av. Antonio Carlos, 6627, Pampulha, Belo Horizonte, 31270-901, Brazil.
- Department of Restorative Dentistry, Dentistry School, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
- Department of Metallurgical and Materials Engineering, Engineering School, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
- Department of Microbiology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
- Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
- Department of Chemistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Zitieren
APA
Lima, L. C. D., Cavalcante, I. R., Rocha, F. E. O., Jorge, J. O., Martins, T., Madeira, M. F. M., Campagnole-Santos, M. J., Macari, S., Nascentes, C. C., Nunes, E. H. M., Queiroz-Junior, C. M., Dos Santos, R. A. S., Moreira, P. R., & de Sá, M. A. (2026). The Alamandine/MrgprD as a Key Player in Antiresorptive Effects in an Osteoporosis Experimental Model. Calcified Tissue International, 117(1). https://doi.org/10.1007/s00223-025-01465-8
Vancouver
Lima LCD, Cavalcante IR, Rocha FEO, Jorge JO, Martins T, Madeira MFM, et al. The Alamandine/MrgprD as a Key Player in Antiresorptive Effects in an Osteoporosis Experimental Model. Calcified Tissue International. 2026;117(1). doi:10.1007/s00223-025-01465-8
BibTeX
@article{Lima2026,
author = {Lima, Letícia Cristina Dias and Cavalcante, Isabella Ramos and Rocha, Felipe Emanuel Oliveira and Jorge, Jader Oliva and Martins, Talita and Madeira, Mila Fernandes Moreira and Campagnole-Santos, Maria José and Macari, Soraia and Nascentes, Clésia Cristina and Nunes, Eduardo Henrique Martins and Queiroz-Junior, Celso Martins and Dos Santos, Robson Augusto Souza and Moreira, Paula Rocha and de Sá, Marcos Augusto},
title = {The Alamandine/MrgprD as a Key Player in Antiresorptive Effects in an Osteoporosis Experimental Model},
journal = {Calcified Tissue International},
year = {2026},
volume = {117},
number = {1},
doi = {10.1007/s00223-025-01465-8}
}
EUVIMED